Blue Torch Aims Low: Negative Medicare NCD Could Boost Business, It Says
This article was originally published in The Gray Sheet
Executive Summary
Blue Torch Medical paradoxically expects that a Medicare national non-coverage decision for its CaverMap diagnostic to assess a patient's risk of impotency after radical prostatectomy will lead to increased sales